David Mahon
About David Mahon
David Mahon is a Senior Scientist at Bristol Myers Squibb with extensive experience in protein characterization and method development.
Professional Experience at Bristol Myers Squibb
David Mahon currently holds the title of Senior Scientist at Bristol Myers Squibb. Since January 2018, David has been involved in various scientific endeavors, notably specializing in both early phase and commercial biologics. His work focuses on advanced protein characterization and method development, utilizing sophisticated techniques such as mass spectrometry, liquid chromatography, and UV/Vis spectroscopy.
Role at Celgene
David Mahon is serving as a Scientist 1 at Celgene. In this capacity, he engages in numerous scientific research and development activities. His role involves utilizing advanced methodologies to contribute to the cutting-edge work being conducted at Celgene. His expertise in both early phase and commercial biologics underscores his contributions to the company's scientific advancement.
Position with Eli Lilly and Company
David Mahon works as a Principal Associate at Eli Lilly and Company. His responsibilities in this role include overseeing significant scientific projects and initiatives. His extensive experience in protein characterization and method development through techniques like mass spectrometry, liquid chromatography, and UV/Vis spectroscopy enable him to make substantial contributions to Eli Lilly's research goals.
Previous Employment at Medarex
David Mahon served as an Associate Scientist at Medarex from 2004 to 2009. Over his five-year tenure, David honed his expertise in biochemistry and microbiology. His role included substantial involvement in scientific research and development, laying a strong foundation for his future positions in the biotechnology and pharmaceutical industries.
Educational Background
David Mahon completed his education at the National University of Ireland, Galway. He earned a Bachelor of Science degree, focusing on biochemistry and microbiology, from 2000 to 2002. Additionally, he attended the J.E. Cairnes School of Business & Economics at NUI Galway, reinforcing his scientific and analytical knowledge. His academic background has provided him with a robust foundation to support his professional expertise.